NCT01680172View on ClinicalTrials.gov

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
CancerDepressionAnxiety
Interventions
DRUG

Ketamine

Single dose (0.5 mg/kg) of liquid ketamine 10mg/mL solution taken by mouth

DRUG

Placebo

Single dose of liquid placebo solution taken by mouth

Trial Locations (2)

85259

Mayo Clinic in Arizona, Scottsdale

85364

Yuma Regional Medical Center, Yuma

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER